Results 81 to 90 of about 2,828,690 (175)

Area Postrema Syndrome: A Lesser Known Variant of Neuromyelitis Optica Spectrum Disorder

open access: yesIndian Journal of Medical Specialities, 2019
One of the most specific presentations of neuromyelitis optica spectrum disorders (NMOSDs) is area postrema syndrome (APS). Although NMOSDs are now being increasingly encountered, APS is rarely reported in literature.
Gaurav Kumar Mittal   +3 more
doaj   +1 more source

Top‐Down CSF Peptidomics Reveals Disease‐Associated Peptide Signatures and Oxidative Modifications in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Multiple sclerosis and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory demyelinating diseases of the CNS whose diagnosis is mainly based on clinical evidence, magnetic resonance imaging, and the analysis of cerebrospinal fluid (CSF). Current approaches provide only partial insight into disease‐related biological processes, thus
Cristina Contini   +9 more
wiley   +1 more source

Targeted therapy for neuromyelitis optica spectrum disorders

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2020
Neuromyelitis optica spectrum disorders (NMOSDs) have the characteristics of high relapse rate and high disability rate. The neurological deficits would become more and more serious with increasing relapse.
Yang⁃tai GUAN
doaj  

Multidisciplinary rehabilitation for adults with neuromyelitis optica spectrum disorders: A pilot study

open access: yesJournal of Rehabilitation Medicine, 2019
Objective: To provide detailed data on the effects of multidisciplinary rehabilitation for patients with neuromyelitis optica spectrum disorder with moderate to severe disability. Design: A pilot randomized control study.
Dong-Mei Suo   +9 more
doaj   +1 more source

The immunological landscape of the area postrema in neuromyelitis optica spectrum disorders

open access: yesBrain Pathology, EarlyView.
Aquaporin‐4 antibody‐positive neuromyelitis spectrum disorder is characterized by large tissue destructive lesions in medulla, spinal cord, and optic nerves, with only partial recovery from clinical symptoms, and by lesions with very little tissue destruction and mostly complete recovery from clinical symptoms, as seen in the area postrema ...
Qian Yu   +11 more
wiley   +1 more source

Inborn errors of immunity in children with neuroinflammation

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Abstract Inborn errors of immunity (IEIs), an expanding group of monogenic disorders with diverse clinical manifestations, are increasingly recognized to include neuroinflammatory disease. Examples of diseases included under this umbrella are Aicardi–Goutières syndrome, deficiency of adenosine deaminase 2, familial haemophagocytic lymphohistiocytosis ...
Eppie M Yiu   +5 more
wiley   +1 more source

Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders

open access: yesFrontiers in Cellular Neuroscience, 2019
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder mediated by immune-humoral responses directed against central nervous system (CNS) antigens.
Ana Paula Bornes da Silva   +6 more
doaj   +1 more source

Rethinking diabetic retinopathy: Homeostatic mechanisms for retinal clearance

open access: yesDiabetic Medicine, EarlyView.
In the healthy retina, balanced production and clearance of metabolic waste and fluid maintain retinal homeostasis and normal visual function. Diabetes disrupts this balance, increasing the accumulation of metabolic waste products, including advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs), while impairing waste and ...
Karis Little   +7 more
wiley   +1 more source

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors

open access: yesInternal Medicine Journal, EarlyView.
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard   +13 more
wiley   +1 more source

Neuromyelitis Optica Spectrum Disorders: Diagnosis and Treatment

open access: yes, 2011
The last decade has witnessed rapid developments in the clinical understanding and scientific foundation of neuromyelitis optica (NMO).curriculum_fellow; IC-E4cii1-relationships-between-optic-neuritis-and-multiple-sclerosis; IC-E4cii3-classification-and ...
Dean M. Wingerchuk, MD, MSc, FRCP(C)
core  

Home - About - Disclaimer - Privacy